SABCS 2021 | Challenges of treating patients with breast cancer with leptomeningeal metastasis

Gaia Griguolo • 26 Nov 2021

Gaia Griguolo, MD, University of Padova, Padova, Italy, discusses the challenges of treating patients with breast cancer who develop leptomeningeal metastases, and covers some of the current treatment options for these patients. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

PI3K inhibitors for the treatment of brain metastases in HER2-negative breast cancer

Gaia Griguolo • 24 May 2021

PerELISA: de-escalated therapy for HR+/HER2+ BC with Ki67 response following 2-week letrozole

Gaia Griguolo • 3 May 2022

HRD, RB-loss gene sig, intrinsic subtype and response to neoadjuvant treatment in HR+/HER2- early BC

Gaia Griguolo • 7 Dec 2022

Adjuvant/neoadjuvant therapy trials for breast cancer at SABCS 2021

Gaia Griguolo • 26 Nov 2021

Related Videos

Highlights in breast and gynecological cancer at ESTRO 2022

Pedro Lara • 17 May 2022

What impact will biosimilars have on clinical life?

Diana Lüftner • 21 Sep 2017

Drug shortages around the world: why communication is key

Fatima Cardoso • 22 Sep 2017

HER-2 conversion: a phenomenon in trastuzumab resistance

Russell Petty • 5 Nov 2019